2024: Small and mid-cap stocks with up to 164 percent price potential - Berenberg recommends 13 stocks to buy.

2024: Small and mid-cap stocks with up to 164 percent price potential - Berenberg recommends 13 stocks to buy.

“It will be the year of small-cap stocks and mid-cap stocks,” say the analysts at Berenberg. That's why they now recommend these values ​​with up to 164 percent price potential.

How www.boerse-online.de reported, Berenberg analysts are favoring small-cap stocks and mid-cap stocks this year due to their poorer performance in the past two years compared to large-cap stocks. Therefore, they recommend 13 stocks with high upside potential, including Befesa, Beijer Ref, CompuGroup Medical, Eventim, Do&Co, SEB Group, GVS, LEM, Nexans, Redcare Pharmacy, Sdiptech, tonies and VusionGroup.

Impact on the market and industry

Berenberg's recommendation has the potential to increase interest and investment in small-cap stocks and mid-cap stocks. This could result in increased liquidity and positive price developments in this segment. Investors could benefit from the expected price increases, while companies could potentially raise additional capital for growth projects.

The specifics of each recommended stock, such as the expected growth at Befesa or the austerity measures at CompuGroup Medical, indicate industry-specific developments that investors should keep a close eye on. In addition, the recommendations give investors the opportunity to invest in companies with promising business prospects that may have previously received less attention.

Berenberg's positive forecasts could also have a signaling effect for other analysts and investors who are increasingly paying attention to small-cap stocks and mid-cap stocks and identifying similar opportunities.